Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronary Heart Disease Risk Reduction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00005163
What this trial is testing

Validation and Field Test for Risk Appraisal Instruments

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCoronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT05148338
What this trial is testing

Prevention to Improve Outcomes After PVI

Who this might be right for
Atrial FibrillationRisk ReductionNurse's Role
Catharina Ziekenhuis Eindhoven 150
Not applicableStudy completedNCT04166643
What this trial is testing

Worksite Wellness Within Long-term Care Facilities

Who this might be right for
Worksite Health PromotionLifestyle Risk ReductionCardiovascular Diseases+2 more
University of Maryland, Baltimore 159
Not applicableStudy completedNCT00005726
What this trial is testing

Evaluation of Low Literacy CVD Nutrition Education

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCoronary Heart Disease Risk Reduction
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableWithdrawnNCT03791580
What this trial is testing

Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase

Who this might be right for
FallCongestive Heart FailureChronic Kidney Failure+1 more
RAND
Large-scale testing (Phase 3)Study completedNCT01492361
What this trial is testing

AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

Who this might be right for
Cardiovascular Diseases
Amarin Pharma Inc. 8,179
Large-scale testing (Phase 3)Ended earlyNCT00263042
What this trial is testing

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Who this might be right for
Cardiovascular Disease
Sanofi 18,695
Not applicableStudy completedNCT03196024
What this trial is testing

Corazon de la Familia (Heart of the Family)

Who this might be right for
Risk Reduction BehaviorDiabetes Mellitus, Type 2Cardiovascular Diseases
Gia Mudd 526
Not applicableStudy completedNCT02579135
What this trial is testing

Reducing HIV Risk Among Adolescents: Evaluating Project HEART

Who this might be right for
HIVSexually Transmitted Diseases
North Carolina State University 222
Not applicableActive Not RecruitingNCT00143923
What this trial is testing

Novel Strategies for Reducing Heart Disease Risk Disparities

Who this might be right for
Cardiovascular Diseases
University of Pittsburgh 2,000
Large-scale testing (Phase 3)Study completedNCT00202878
What this trial is testing

IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)

Who this might be right for
HypercholesterolemiaMyocardial Infarction
Organon and Co 18,144
Large-scale testing (Phase 3)Study completedNCT01877915
What this trial is testing

Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Who this might be right for
Heart FailureCoronary Artery Disease
Janssen Research & Development, LLC 5,081
Not applicableStudy completedNCT06178263
What this trial is testing

Adherence to an Exercise and Healthy Diet Program in Patients With Coronary Heart Disease Aged ≥ 60 Years

Who this might be right for
Coronary Heart DiseaseRisk Reduction BehaviorAdherence, Treatment
University Medicine Greifswald 37
Not applicableNot Yet RecruitingNCT07415642
What this trial is testing

Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

Who this might be right for
Sudden Cardiac Death
University Medical Center Groningen 720
Early research (Phase 1)Study completedNCT01235702
What this trial is testing

Metro Atlanta Heart Disease Study - II (MAHDS II)

Who this might be right for
African Americans With Hypertension.
Morehouse School of Medicine 210
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Not applicableWithdrawnNCT02113722
What this trial is testing

Is Left Stellate Ganglionectomy Beneficial to Patients With Life Threatening Ventricular Arrhythmias

Who this might be right for
Sudden Cardiac Death
Cindy Hall
Post-approval studies (Phase 4)Looking for participantsNCT05262803
What this trial is testing

Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction

Who this might be right for
Myocardial Infarction
Rikke Sorensen 2,808
Large-scale testing (Phase 3)Active Not RecruitingNCT06383390
What this trial is testing

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Eli Lilly and Company 10,000
Not applicableStudy completedNCT00790491
What this trial is testing

Automated Guidance Tool for Medical Encounters Addressing Therapeutic Lifestyle Changes (AuGMEnT).

Who this might be right for
Heart DiseaseDiabetes
Griffin Hospital 240
Next Page